EcoDrugPlus

Endothelial Pas Domain Protein 1

Ensembl ID : ENSCHOG00000005351
Gene Symbol: EPAS1
1 Cross references
225 Possible Orthologues:

Endothelin Converting Enzyme 1

Ensembl ID : ENSCHOG00000004045
Gene Symbol: ECE1
1 Cross references
230 Possible Orthologues:

Endothelin Receptor Type A

Ensembl ID : ENSCHOG00000013051
Gene Symbol: EDNRA
1 Cross references
269 Possible Orthologues:

Endothelin Receptor Type B

Ensembl ID : ENSCHOG00000008749
Gene Symbol: EDNRB
1 Cross references
266 Possible Orthologues:

Enhancer Of Zeste 2 Polycomb Repressive Complex 2 Subunit

Ensembl ID : ENSCHOG00000013009
Gene Symbol: EZH2
1 Cross references
236 Possible Orthologues:

Epidermal Growth Factor Receptor

Ensembl ID : ENSCHOG00000002830
Gene Symbol: EGFR
1 Cross references
287 Possible Orthologues:

Epoxide Hydrolase 2

Ensembl ID : ENSCHOG00000008246
Gene Symbol: EPHX2
1 Cross references
204 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 3

Ensembl ID : ENSCHOG00000007146
Gene Symbol: ERBB3
1 Cross references
280 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 4

Ensembl ID : ENSCHOG00000012042
Gene Symbol: ERBB4
1 Cross references
320 Possible Orthologues:

Estrogen Receptor 2

Ensembl ID : ENSCHOG00000012987
Gene Symbol: ESR2
1 Cross references
274 Possible Orthologues:

Estrogen Related Receptor Gamma

Ensembl ID : ENSCHOG00000007612
Gene Symbol: ESRRG
1 Cross references
202 Possible Orthologues:

Exportin 1

Ensembl ID : ENSCHOG00000012088
Gene Symbol: XPO1
1 Cross references
296 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).